IQSI - ETF AI Analysis

Top Page

IQ Candriam ESG International Equity ETF (IQSI)

Rating:67Neutral

Price Target:―

IQSI, the IQ Candriam ESG International Equity ETF, has a solid overall rating driven mainly by high-quality global leaders like Novartis, AstraZeneca, Toyota, and ASML, which show strong financial performance, healthy balance sheets, and generally supportive technical trends. This strength is partly offset by holdings such as SAP, Schneider Electric, and Commonwealth Bank of Australia, where bearish technical signals, valuation concerns, and leverage or cash flow issues weigh on the fund’s appeal. The main risk factor is its meaningful exposure to a few large international names and sectors where some stocks appear expensive or under technical pressure, which could increase volatility.

Positive Factors

Solid Recent Performance

The ETF has shown steady gains over the past month, three months, and year-to-date, indicating positive recent momentum.

Broad International Diversification

Holdings spread across many countries, with meaningful exposure to Japan, the UK, Switzerland, Australia, and others, help reduce reliance on any single market.

Low Expense Ratio

The fund’s relatively low fee means less of your return is eaten up by costs compared with many actively managed products.

Negative Factors

Country Concentration in Japan

A large portion of the portfolio is invested in Japanese stocks, which can increase the impact of economic or market issues specific to Japan.

Mixed Performance Among Top Holdings

While some leading positions like ASML and Toyota have performed strongly, several other top holdings have been weak, which can drag on overall returns.

Sector Tilt Toward Financials and Industrials

Heavy exposure to financial and industrial companies may make the ETF more sensitive to economic cycles and interest-rate changes.

IQSI vs. SPDR S&P 500 ETF (SPY)

AUM232.89M

RegionDeveloped Markets

Expense Ratio0.15%

Beta0.71

IssuerNew York Life Investments

Inception DateDec 17, 2019

Dividend Yield2.54%

Asset ClassEquity

Index TrackedIQ Candriam ESG International Equity Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume18,504

30 Day Avg. Volume9,627

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

41.33

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering604

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

IQSI Summary

IQ Candriam ESG International Equity ETF (IQSI) is a fund that tracks the IQ Candriam ESG International Equity Index, focusing on stocks from many countries outside the U.S. It invests in companies that meet environmental, social, and governance (ESG) standards, aiming to back businesses that act responsibly. The fund holds well-known names like Toyota, Nestlé, ASML, and Novartis, and spreads your money across many sectors and countries for diversification and long-term growth potential. A key risk is that international stock prices can go up and down with global markets and currency moves.

How much will it cost me?The IQ Candriam ESG International Equity ETF (IQSI) has an expense ratio of 0.15%, which means you’ll pay $1.50 per year for every $1,000 invested. This is lower than average for ETFs because it is passively managed, tracking an index rather than relying on active management.

What would affect this ETF?The IQ Candriam ESG International Equity ETF could benefit from growing global interest in ESG investing, as more individuals and institutions prioritize sustainability and ethical practices. However, its exposure to developed markets and sectors like Financials and Industrials may face challenges if economic growth slows or interest rates rise, which could impact corporate profitability. Additionally, regulatory changes or geopolitical tensions in key regions could create uncertainty for some of its top holdings.

IQSI Top 10 Holdings

IQSI leans heavily on Europe and other developed markets, and its story right now is a tug-of-war between surging tech and softer defensives. ASML is the clear engine of performance, with rising momentum that helps offset weakness elsewhere. Health care heavyweights Roche and Novartis are steady climbers, quietly supporting returns, while AstraZeneca is more mixed. On the other side, consumer staple giant Nestlé and software leader SAP have been lagging, acting like a small anchor on an otherwise solid, broadly diversified international ESG portfolio.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
ASML	ASML Holding NV	3.93%	$9.15M	€475.49B	74.46%	76 Outperform
ROG	Roche Holding AG	2.36%	$5.49M	CHF294.84B	46.01%	73 Outperform
NOVN	Novartis AG	2.16%	$5.02M	CHF242.43B	28.84%	80 Outperform
AZN	AstraZeneca	2.15%	$5.01M	$323.92B	30.42%	80 Outperform
NESN	Nestlé SA	1.85%	$4.31M	CHF198.29B	10.92%	71 Outperform
7203	Toyota Motor	1.73%	$4.03M	¥48.61T	34.33%	80 Outperform
SIE	Siemens	1.50%	$3.49M	€191.01B	9.25%	74 Outperform
CBA	Commonwealth Bank of Australia	1.49%	$3.47M	AU$295.71B	18.41%	64 Neutral
SAP	SAP SE	1.44%	$3.36M	€197.41B	-36.18%	66 Neutral
SU	Schneider Electric	1.16%	$2.70M	€147.11B	0.62%	62 Neutral

IQSI Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

36.30

Positive

100DMA

35.24

Positive

200DMA

33.96

Positive

Market Momentum

MACD

0.61

Negative

RSI

67.91

Neutral

STOCH

75.82

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IQSI, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 37.57, equal to the 50-day MA of 36.30, and equal to the 200-day MA of 33.96, indicating a bullish trend. The MACD of 0.61 indicates Negative momentum. The RSI at 67.91 is Neutral, neither overbought nor oversold. The STOCH value of 75.82 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IQSI.

IQSI Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
IQSI	―	―	$232.89M	0.15%	―
URTH	―	―	$6.88B	0.24%	―
GSWO	―	―	$1.57B	0.15%	―
WSML	―	―	$843.74M	0.30%	―
GDIV	―	―	$226.35M	0.50%	―
QWLD	―	―	$187.15M	0.30%	―

Performance Comparison

IQSI

IQ Candriam ESG International Equity ETF

38.45

8.83

29.81%

URTH

iShares MSCI World ETF

―

GSWO

Goldman Sachs ActiveBeta World Equity ETF

―

WSML

iShares MSCI World Small-Cap ETF

―

GDIV

Harbor Dividend Growth Leaders ETF

―

QWLD

SPDR MSCI World StrategicFactors ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents